Stay updated on Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.4.3 was added and v3.4.2 removed. This is a minor UI/versioning update that does not alter study details or user-facing content.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added, while the prior Revision: v3.4.1 and a government funding/operating status notice were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and the NIH Clinical Center staying open, and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check48 days agoChange DetectedMinor wording and metadata updates were applied: the labels 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' were adjusted in capitalization, and the revision/version was updated from v3.3.4 to v3.4.0; a 'Show glossary' control is now displayed.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision metadata was updated: Revision: v3.3.4 added and Revision: v3.3.3 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check84 days agoChange DetectedThe Locations section was updated to add several new sites and regions and remove some existing location groupings; the revision is now v3.3.3.SummaryDifference1%

Stay in the know with updates to Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial page.